Clinical Trial: IBI343 in Combination Therapy for Advanced Malignant Solid Tumors

U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT07483554) titled 'IBI343 in Combination Therapy for Advanced Malignant Solid Tumors' on March 16.

Brief Summary: A Phase II study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of IBI343 in combination therapy for patients with advanced malignant solid tumors.To evaluate the efficacy and safety of IBI343 in combination therapy for patients with advanced malignant solid tumors.Enrollment of subjects with advanced gastric/gastroesophageal junction adenocarcinoma positive for CLDN18.2, and subjects with pancreatic ductal adenocarcinoma positive for CLDN18.2.

Study Start Date: March 25

Study Type: INTERVENTIONAL

Condition: CLDN...